LLMpediaThe first transparent, open encyclopedia generated by LLMs

Paschen, Silke

Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Qimiao Si Hop 6 terminal

This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.

Paschen, Silke
NameSilke Paschen
Birth date1960s
Birth placeGermany
OccupationNeuroscientist; Professor
Alma materHumboldt University of Berlin; Max Planck Society
EmployerMassachusetts General Hospital; Harvard Medical School

Paschen, Silke is a neuroscientist known for contributions to stroke research, cerebral ischemia, and neuroprotection. She has held positions at major institutions and collaborated with clinical and basic science investigators on mechanisms of neuronal injury and recovery. Her work bridges translational neuroscience, pharmacology, and clinical neurology, influencing protocols in acute ischemic stroke and neurovascular research.

Early life and education

Born in Germany, Paschen completed early studies at Humboldt University of Berlin and trained within the Max Planck Society system, where she was exposed to laboratories linked to Otto Meyerhof-era physiology and modern neurobiology. She pursued doctoral research under supervisors connected to the German Research Foundation and obtained a Ph.D. in neurobiology, emphasizing models of cerebral ischemia and cell death pathways. Postdoctoral work included fellowships at laboratories affiliated with Charité – Universitätsmedizin Berlin and collaborations with researchers from University College London and the National Institutes of Health, consolidating expertise in translational models used by clinicians at Massachusetts General Hospital and investigators at Harvard Medical School.

Academic and research career

Paschen established a research program integrating molecular neuroscience with clinical neurology, collaborating with investigators at Massachusetts General Hospital, Harvard Medical School, and European centers such as University of Munich and Karolinska Institutet. Her group investigated mechanisms underlying neuronal vulnerability in ischemia, including calcium dysregulation, endoplasmic reticulum stress, and apoptotic signaling cascades studied alongside teams from the Max Delbrück Center for Molecular Medicine and the Wellcome Trust-funded consortia. She participated in multicenter projects with partners at Oxford University, University of Cambridge, Columbia University, and the University of Pennsylvania to translate laboratory findings into therapeutic strategies, interacting with stroke clinicians from Johns Hopkins University and trialists associated with the European Stroke Organization. Paschen supervised graduate students and postdoctoral fellows who moved to positions at institutions such as the Salk Institute, Cold Spring Harbor Laboratory, and the National Institute of Neurological Disorders and Stroke.

Her laboratory employed methods developed in collaboration with researchers from Massachusetts Institute of Technology, ETH Zurich, and Imperial College London, integrating imaging technologies used in studies at Yale School of Medicine and proteomic approaches pioneered at Max Planck Institute for Biochemistry. Paschen contributed to consensus statements and guidelines drafted with committees from the American Heart Association and the World Health Organization working groups on stroke, engaging with health services at St Thomas' Hospital and policy teams from the European Commission.

Major works and publications

Paschen authored and coauthored articles in journals including Nature Medicine, The Lancet Neurology, Neuron, Journal of Neuroscience, and Brain. Her publications addressed endoplasmic reticulum stress in neuronal death, mechanisms of delayed neuronal death in global ischemia, and strategies for neuroprotection in focal ischemia, often citing foundational work from Rita Levi-Montalcini, Seymour Benzer, and contemporaries at Columbia University Irving Medical Center. She contributed chapters to edited volumes published by academic presses connected to Oxford University Press and Cambridge University Press, and participated in symposia organized by Society for Neuroscience, European Academy of Neurology, and the American Neurological Association.

Representative papers include mechanistic studies that built upon signaling frameworks described in research from Harvard University laboratories and translational reports developed in partnership with clinicians at Addenbrooke's Hospital and Massachusetts General Hospital. She was a frequent invited speaker at conferences such as the World Congress of Neurology, the Federation of European Neuroscience Societies meetings, and the International Stroke Conference.

Awards and honors

Paschen received recognition from national and international bodies, including awards from the German Society of Neurology, fellowships from the Alexander von Humboldt Foundation, and grants from the European Research Council and the National Institutes of Health. She was elected to committees within the German Research Foundation and served on advisory panels for the European Commission and the Wellcome Trust. Her laboratory received program project funding from the National Institute of Neurological Disorders and Stroke and career awards linked to the European Molecular Biology Organization and the American Heart Association.

Personal life and legacy

Paschen maintained collaborations across continents, mentoring researchers who continued work at institutions including Stanford University, University of Toronto, and University of Melbourne. Her legacy includes contributions to understanding ischemic neuronal injury, influencing clinical trial designs at centers such as Mayo Clinic and Cleveland Clinic and shaping curricula at Harvard Medical School and European universities. Through service on editorial boards of journals like Stroke and Journal of Cerebral Blood Flow & Metabolism, and participation in guideline committees for the American Academy of Neurology, she impacted policy and practice in neurology and neuroscience. Paschen's students and collaborators continue to cite her work in ongoing research at centers such as the Scripps Research Institute and the J. Craig Venter Institute.

Category:German neuroscientists Category:Stroke researchers